Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01307865
Other study ID # EFW-001-SA
Secondary ID
Status Completed
Phase Phase 4
First received March 2, 2011
Last updated October 13, 2013
Start date January 2011
Est. completion date June 2013

Study information

Verified date October 2013
Source Williams Center Plastic Surgery Specialists
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to examine the effect of Sculptra Aesthetic on the cosmetic rejuvenation of the midface complex. The investigators plan to both qualitatively determine the restoration of midface architecture as well as quantitatively document the change in midface volume by employing three-dimensional (3D) surface imaging which critically analyzes volumetric tissue changes. Our hypothesis is that patients who receive Sculptra Aesthetic injections will experience significant improvement in facial midface volume restoration.

- Measure the midfacial volumetric correction from Sculptra Aesthetic treatment, using three-dimensional digital surface imaging

- Determine the mean change from baseline in facial contour via quantitative volumetric measurements

- Correlate volumetric correction with clinical improvement as measured by the Facial Lipoatrophy Panel grading system

- Correlate the mean volumetric change in midfacial treatment area with the amount of product used

- Obtain photographs pre- and post-treatment for the purpose of providing a subject visual aid during the course of treatment

- Collect safety data


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date June 2013
Est. primary completion date June 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 60 Years
Eligibility Inclusion Criteria:

- Age 40-60 years old

- BMI greater than 18.5 and less than 24.9

Exclusion Criteria:

- Age less than 40 years or greater than 60 years

- Prior surgical or non-surgical treatment to the midface within the past 2 years

- Interested in seeking other treatments to the midface during the study period

- Pregnant, lactating, or breast feeding

- Hypersensitivity to poly-L-lactic acid, carboxymethylcellulose, or mannitol

- Allergy to lidocaine or epinephrine

- History of atopy, anaphylaxis, or multiple severe allergies

- Current immunotherapy or history of autoimmune disease

- History of or active stroke or myocardial infarction

- History of or active connective tissue disease

- History of or active bleeding disorders

- History of or active cancer

- Serious abnormalities in laboratory findings

- Active hepatitis

- Active infection or inflammatory process of skin

- History of or risk factors for hypertrophic scarring or keloid formation

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
injectable poly-L-lactic acid
Each patient will receive up to 1 vial of Sculptra Aesthetic total to both midface complexes at each of 3 treatment sessions, spaced 6 weeks apart.

Locations

Country Name City State
United States Williams Center Plastic Surgery Specialists Latham New York

Sponsors (2)

Lead Sponsor Collaborator
Williams Center Plastic Surgery Specialists Sanofi

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in midfacial volume from Sculptra Aesthetic treatment, using three-dimensional digital surface imaging 6 mo, 9 mo, 12 mo, 15 mo
Secondary Correlate volumetric correction with clinical improvement as measured by the Facial Lipoatrophy Panel grading system 12 mo
Secondary Correlate the mean volumetric change in midfacial volume with the amount of product used 12 mo
Secondary Time course and duration of volumetric correction from Sculptra Aesthetic treatment 6 mo
Secondary Time course and duration of volumetric correction from Sculptra Aesthetic treatment 9 mo
Secondary Time course and duration of volumetric correction from Sculptra Aesthetic treatment 12 mo
Secondary Time course and duration of volumetric correction from Sculptra Aesthetic treatment 15 mo
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02679924 - A Slit Face Trial Using Micro-injections of Transparent Hyaluronic Acid Gel for Rejuvenation of the Cheek N/A
Completed NCT02651233 - Factors That Influence Adipose Derived Regenerative Cells' Yield and Viability N/A
Completed NCT01365104 - Modulation of Cerebral Blood Flow Using Iron Chelators Phase 0
Completed NCT01376011 - Modulation of Cerebral Blood Flow Using Quercetin, a Nutritional Supplement Phase 0
Completed NCT02532725 - Work-Related Effects of Heat, Activity, and Fat in Middle Aged Men N/A